Cite
HARVARD Citation
André, F. et al. (n.d.). Ribociclib + letrozole for first-line treatment of HR+, HER2− ABC: efficacy, safety, and pharmacokinetics. European journal of cancer. pp. S7-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
André, F. et al. (n.d.). Ribociclib + letrozole for first-line treatment of HR+, HER2− ABC: efficacy, safety, and pharmacokinetics. European journal of cancer. pp. S7-. [Online].